Hartford HealthCare earns multiple awards from Leapfrog Costs of Care and The Leapfrog Group today announced that Jeffrey A.Flaks, President and Chief Executive Officer of Hartford HealthCare, has been awarded the Steven Schroeder Award for Outstanding Healthcare CEO. The prestigious award recognizes courageous and ethical leadership in addressing the twin challenges of quality and affordability […]

Vancouver, British Columbia–(Newsfile Corp. – December 15, 2025) – Dixie Gold Inc. (TSXV: DG) (“Dixie Gold” or the “Corporation” or the “Issuer“) reports that it has filed its management information circular (the “Meeting Circular”) and related materials in connection with its upcoming annual general and special meeting of shareholders, to be held in Vancouver, BC

(AUST:SZL.AX),(NASDAQ:SEZL), Minneapolis, MN, Dec. 15, 2025 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today, announced its Board of Directors authorized the repurchase of an additional $100 million of the Company's common stock after the completion of its $50.0 million stock repurchase program announced on March 10, 2025.

Sezzle Authorizes $100 Million Stock Repurchase Program after Completing $50 Million Program GlobeNewswire December 15, 2025 Minneapolis, MN, Dec. 15, 2025 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today, announced its Board of Directors authorized the repurchase of an additional $100 million of the Company's common stock

Toronto, Ontario–(Newsfile Corp. – December 15, 2025) – Mines D’Or Orbec Inc. (TSXV: BLUE) (OTC Pink: BLTMF) (“Orbec” or the “Company“) is pleased to announce that at its special meeting of shareholders (the “Shareholders“), holders of incentive stock options (“Optionholders“), and holders of common share purchase warrants (“Warrantholders“, and together with the Shareholders and Optionholders,

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced that it has commenced an underwritten public offering of 6,000,000 of shares of its common stock. In connection with the proposed offering, Kodiak Sciences expects to grant the underwriters a 30-day option to purchase

Second Quarter 2025 Net Income of $137.5 Million in Line with Previous Estimate of $120 Million to $140 Million Second Quarter 2025 Form 10-Q Filed Prior to Nasdaq's December 23, 2025 Deadline B. Riley Financial, Inc. (NASDAQ: RILY) (“BRF” or the “Company”), a diversified holding company, today announced the filing of its Quarterly Report on

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12 at 7:30 a.m. PT. https://mma.prnewswire.com/media/2460831/Grail_Logo.jpg Live and replay webcasts may be accessed in the

(NASDAQ:KYTX), EMERYVILLE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX) (“Kyverna”), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that it has commenced an underwritten public offering of $100,000,000 of shares of its common stock. Kyverna intends to grant the underwriters a 30-day

(TSX:FRU), CALGARY, Alberta, Dec. 15, 2025 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on January 15, 2026 to shareholders of record on December 31, 2025. These dividends are designated as “eligible dividends” for Canadian